<DOC>
	<DOCNO>NCT00864279</DOCNO>
	<brief_summary>To determine pharmacokinetics bioequivalence cetirizine hydrochloride formulation administration single dos normal healthy subject fast condition . These data evaluate statistically determine product meet bioequivalence criterion .</brief_summary>
	<brief_title>A Relative Bioavailability Study Cetirizine HCl 10 mg Tablets Under Fasting Conditions</brief_title>
	<detailed_description>Study Type : Interventional Study Design : Single-dose two-way , crossover bioequivalence study adequate washout period ( 7 day ) two period study equal number subject randomly assign receive study test ( Treatment A ) study reference ( Treatment B ) . Official Title : Single Dose Two-Way Crossover Fasted Bioequivalence Study Cetirizine Hydrochloride 10 mg Tablets Healthy Volunteers Further study detail provide Actavis Elizabeth LLC : Primary Outcome Measures : Rate Extend Absorption</detailed_description>
	<mesh_term>Cetirizine</mesh_term>
	<criteria>1 . Healthy subject least 18 year age . 2 . Informed nature study provide write informed consent . 3 . Have body mass index2 18 30 weigh least 110 pound . 4 . In good health determine lack clinically significant abnormality health assessment perform screen judged physician . 1 . Hypersensitivity cetirizine hydrochloride ( Zyrtec® ) relate compound . 2 . Conditions affect absorption , metabolism passage drug body , e.g. , sprue , celiac disease , Crohn 's disease , colitis , liver , kidney thyroid condition . 3 . Recent history ( within 1 year ) mental illness , drug addiction , drug abuse alcoholism . 4 . A hematocrit value ≤ 33.0 % female ≤ 37.0 % male . 5 . Donation great 500 ml blood past 4 week prior study dose difficulty donate blood . 6 . Received investigational drug within 4 week prior study dose . 7 . Currently take systemic prescription medication , except oral/cutaneous/vaginal hormone contraceptive , within 7 day prior study dose overthecounter medication within 3 day study dose . This prohibition include vitamin herbal preparation take nutritional supplement nontherapeutic indication judge attend physician . Any nonprescription medication consumption report reviewed investigator prior dose . At discretion investigator volunteer may enrol medication anticipate alter study integrity . 8 . Regular smoke 5 cigarette weekly regular daily use nicotinecontaining product begin 3 month study medication administration final evaluation . 9 . If female , subject lactate positive pregnancy test screen prior treatment period . Females must use medically acceptable method contraception throughout entire study period one week study complete . Medically acceptable method contraception may use subject and/or partner : oral contraceptives/patches , progestin injection implant , condom spermicide , diaphragm spermicide , IUD , vaginal spermicidal hormonal suppository , surgical sterilization partner ( ) abstinence . Females take oral contraceptives/patches must take consistently least three month prior receive study medication . 10 . Grapefruit beverages food begin 7 day study medication administration alcohol , caffeine xanthine beverage foods begin 24 hour study medication administration last PK sample period . Such restricted item include coffee , tea , iced tea , Coke® , Pepsi® , Mountain DeW® , chocolate , brownie , etc . 11 . Regular use drug know induce inhibit hepatic drug metabolism ( example include barbiturate , carbamazepine , rifampin , phenylhydantoins , phenothiazine , cimetidine , omeprazole , macrolides , imidazole , fluoroquinolones ) within 30 day prior study administration . 12 . Positive test result : HIV , Hepatitis B surface antigen , Hepatitis C antibody screen . 13 . Positive test result : drug abuse pregnancy screen prior dosing period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Cetirizine</keyword>
	<keyword>Healthy subject</keyword>
</DOC>